VITA 34 Future Growth
Future criteria checks 0/6
VITA 34 is forecast to grow earnings and revenue by 9.8% and 2.9% per annum respectively. EPS is expected to grow by 12.6% per annum. Return on equity is forecast to be -9.4% in 3 years.
Key information
9.8%
Earnings growth rate
12.6%
EPS growth rate
Healthcare earnings growth | 20.7% |
Revenue growth rate | 2.9% |
Future return on equity | -9.4% |
Analyst coverage | Low |
Last updated | 04 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 84 | N/A | N/A | N/A | 1 |
12/31/2025 | 82 | -1 | 5 | 8 | 1 |
12/31/2024 | 79 | -2 | 6 | 8 | 1 |
12/31/2023 | 77 | -2 | 5 | 9 | N/A |
9/30/2023 | 75 | -25 | -5 | 0 | N/A |
6/30/2023 | 73 | -24 | -6 | 1 | N/A |
3/31/2023 | 71 | -27 | -10 | -3 | N/A |
12/31/2022 | 69 | -27 | -11 | -4 | N/A |
9/30/2022 | 63 | -12 | -6 | 0 | N/A |
6/30/2022 | 50 | -11 | -5 | -1 | N/A |
3/31/2022 | 39 | -6 | -1 | 2 | N/A |
12/31/2021 | 28 | -4 | 0 | 3 | N/A |
9/30/2021 | 21 | 0 | 2 | 3 | N/A |
6/30/2021 | 21 | 0 | 3 | 3 | N/A |
3/31/2021 | 20 | 1 | 3 | 4 | N/A |
12/31/2020 | 20 | 1 | 3 | 4 | N/A |
9/30/2020 | 20 | 1 | 4 | 5 | N/A |
6/30/2020 | 20 | 1 | 5 | 6 | N/A |
3/31/2020 | 20 | 1 | 5 | 6 | N/A |
12/31/2019 | 20 | 1 | 5 | 6 | N/A |
9/30/2019 | 20 | 1 | 5 | 6 | N/A |
6/30/2019 | 20 | 1 | 5 | 5 | N/A |
3/31/2019 | 20 | 1 | 5 | 5 | N/A |
12/31/2018 | 20 | 1 | 4 | 5 | N/A |
9/30/2018 | 21 | 2 | 3 | 4 | N/A |
6/30/2018 | 21 | 1 | 2 | 3 | N/A |
3/31/2018 | 20 | 0 | 1 | 2 | N/A |
12/31/2017 | 19 | 0 | 1 | 2 | N/A |
9/30/2017 | 18 | -1 | N/A | 2 | N/A |
6/30/2017 | 16 | -1 | N/A | 2 | N/A |
3/31/2017 | 17 | 1 | N/A | 2 | N/A |
12/31/2016 | 16 | 0 | N/A | 2 | N/A |
9/30/2016 | 16 | 2 | N/A | 1 | N/A |
6/30/2016 | 16 | 2 | N/A | 1 | N/A |
3/31/2016 | 15 | 2 | N/A | 1 | N/A |
12/31/2015 | 14 | 2 | N/A | 3 | N/A |
9/30/2015 | 14 | 1 | N/A | 2 | N/A |
6/30/2015 | 14 | 1 | N/A | 2 | N/A |
3/31/2015 | 14 | 1 | N/A | 2 | N/A |
12/31/2014 | 14 | 1 | N/A | 1 | N/A |
9/30/2014 | 14 | 1 | N/A | 2 | N/A |
6/30/2014 | 13 | 1 | N/A | 2 | N/A |
3/31/2014 | 14 | 1 | N/A | 2 | N/A |
12/31/2013 | 14 | 1 | N/A | 2 | N/A |
9/30/2013 | 13 | 0 | N/A | 2 | N/A |
6/30/2013 | 13 | 0 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: V3V is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: V3V is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: V3V is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: V3V's revenue (2.9% per year) is forecast to grow slower than the German market (5% per year).
High Growth Revenue: V3V's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: V3V is forecast to be unprofitable in 3 years.